Bliss GVS Pharma Limited
NSE: BLISSGVS.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Shibroor Narsimha Kamath
- Employees
- 831
- Headquarters
- Mumbai, India
- IPO year
- 2010
- Market cap
- ₹28.5B
- Website
- https://www.blissgvs.com
Loading BLISSGVS…
Loading profile data…Frequently asked questions about BLISSGVS
What does Bliss GVS Pharma Limited (BLISSGVS.NS) do?
Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals...
Where does BLISSGVS.NS trade?
Bliss GVS Pharma Limited (BLISSGVS.NS) trades on the National Stock Exchange of India.
What sector is BLISSGVS.NS in?
Bliss GVS Pharma Limited (BLISSGVS.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Bliss GVS Pharma Limited?
Shibroor Narsimha Kamath is the chief executive officer of Bliss GVS Pharma Limited (BLISSGVS.NS).
Where is Bliss GVS Pharma Limited headquartered?
Bliss GVS Pharma Limited is headquartered in India.
Does BLISSGVS.NS pay a dividend?
Yes — Bliss GVS Pharma Limited (BLISSGVS.NS) paid a trailing twelve-month dividend of INR 1.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did BLISSGVS.NS go public?
Bliss GVS Pharma Limited (BLISSGVS.NS) completed its initial public offering in 2010.